LS

Liby Silvester

Active Director Managing Director DIN 10665080
DIN 10665080 First appointment Jun 2024 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value •••• Premium profile

About Liby Silvester

Data last updated:

Liby Silvester is a Managing Director at Chris&Caide Pharma Private Limited (since 2024). The company operates in Paper. Chris&Caide Pharma Private Limited reported revenue of ₹41.4 Lakh (FY 2025).

DIN 10665080
Primary Designation Managing Director
Industry Paper
First Appointment 12 Jun 2024
Oldest Company Age 2 yrs
Largest company Chris&Caide Pharma Private Limited · ₹41.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chris&Caide Pharma Private Limited U21003KA2024PTC189589
Managing Director12 Jun 20242024₹41.4 Lakh (FY 2025)Active

Board colleagues of Liby Silvester

NameDINCompanyDesignation
Sweety Silvester07491673Chris&Caide Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Chris&Caide Pharma Private Limited
Premium access

Shareholding and investment profile for Liby Silvester

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Liby Silvester

Liby Silvester currently holds 1 directorship: Chris&Caide Pharma Private Limited (Managing Director, since 12 Jun 2024, revenue ₹41.4 Lakh (FY 2025)).

Liby Silvester was first appointed on 12 Jun 2024 as Managing Director at Chris&Caide Pharma Private Limited.

The current boards of Liby Silvester's companies include Sweety Silvester (Chris&Caide Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available